Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease

NCT04882566 | Unknown

• 1 other identifier: Nutrition in IBD patients
• Study Type: observational
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

Patients with inflammatory bowel disease (IBD) are increasingly becoming interested in nonpharmacologic approaches to their disease. One of the most frequently asked questions of IBD patients is what they should eat. The role of diet has become very important in the prevention and treatment of IBD. Although there is a general lack of rigorous scientific evidence that demonstrates which diet is best for certain patients, several diets have become popular. Aim of the Work To assess IBD patients' knowledge about the role of nutrition in the management of their Inflammatory Bowel Disease and the dietary beliefs, behaviors, and daily dietary practices in adult IBD patients that they make to avoid exacerbation of disease symptoms or to gain more control of bowel symptoms, keeping in mind our traditional and oriental food and food habits in Egypt. Also to evaluate the role of one of the most common dietary regimens; the Paleolithic diet in active mild or moderate inflammatory bowel disease.

Conditions

Ulcerative Colitis; Crohn Disease; Nutrition

Keywords

Paleolithic; Nutrition; Questionnaire; Inflammatory Bowel Disease; Nutritional assessment; Ulcerative colitis; Crohn's disease; Diet

Outcome Measures

Primary Outcomes (1)

• Evaluation of nutritional knowledge among IBD patients

  A self-administered questionnaire was formed of 30 questions assessing the following sub-domains. The questionnaire was developed after reviewing the literature on IBD patient's dietary habits, beliefs, therapies, and attitudes. Based on this literature study, relevant topics for the questionnaire were identified. Also, the draft questionnaire was thoroughly discussed with the IBD patient and modified because of practical aspects and face validity. The questionnaire included 30 close-ended questions, which were divided into 5 sub-domains: 1. General characteristics of the participants ( age, sex, residency, occupation, special habits, IBD type, IBD site in the GIT, disease activity, type of medication, and if there were any complications) 2. Nutritional knowledge 3. Dietary beliefs 4. Dietary behaviors and practices 5. The source of the dietary advice.

  1 year

Other Outcomes (4)

• Role of Paleolithic diet in improving IBD patients symptoms

  1month

• Role of Paleolithic diet in improving IBD patients Quality of Life

  1 month

• Role of Paleolithic diet in induction of laboratory Remission by its effect on CRP

  1 month

Interventions

Paleolithic Diet OTHER

Advice to follow Paleolithic Diet for Inflammatory bowel disease Patients

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Patients with Inflammatory Bowel disease either Ulcerative colitis or Crohn's disease who are in remission and activity.

You may qualify if:

• All patients diagnosed to have Inflammatory bowel disease either Crohn's disease or Ulcerative Colitis attending our Inflammatory bowel disease outpatient clinic at Al-Rajhy Liver Hospital for any reason, either in remission or in activity at Al-Rajhy Liver Hospital at Al-Rajhy Liver Hospital were included in our study.

You may not qualify if:

• Severe disease and critical patients in the Intensive Care Unit with severe exacerbation were excluded from the study. Patients who were not surely diagnosed to have IBD were excluded from the study. Patients with pure perianal CD, a current stoma, previous extensive GI resection, or a current stricture were excluded. Patients were excluded if they had significant comorbidities, or if they were pregnant or lactating. Also, patients with any other acute illness and those who underwent gastrointestinal surgical interventions due to any cause were excluded from the study.

Sponsors & Collaborators

• Assiut University: lead

Related Publications (3)

• Knight-Sepulveda K, Kais S, Santaolalla R, Abreu MT. Diet and Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2015 Aug;11(8):511-20.

  PMID: 27118948 BACKGROUND

• Lee D, Albenberg L, Compher C, Baldassano R, Piccoli D, Lewis JD, Wu GD. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology. 2015 May;148(6):1087-106. doi: 10.1053/j.gastro.2015.01.007. Epub 2015 Jan 15.

  PMID: 25597840 BACKGROUND

• Esmat S, El Nady M, Elfekki M, Elsherif Y, Naga M. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt. World J Gastroenterol. 2014 Jan 21;20(3):814-21. doi: 10.3748/wjg.v20.i3.814.

  PMID: 24574754 BACKGROUND

MeSH Terms

Conditions

Colitis, Ulcerative; Crohn Disease; Inflammatory Bowel Diseases

Interventions

Diet, Paleolithic

Condition Hierarchy (Ancestors)

Colitis; Gastroenteritis; Gastrointestinal Diseases; Digestive System Diseases; Colonic Diseases; Intestinal Diseases

Intervention Hierarchy (Ancestors)

Diet Therapy; Nutrition Therapy; Therapeutics; Diet; Nutritional Physiological Phenomena; Diet, Food, and Nutrition; Physiological Phenomena

Study Officials

• Kerollos L Labib, MSC

  Assiut University

  STUDY DIRECTOR

Central Study Contacts

Kerollos L Labib, MSC

CONTACT

01277111356; dr.kerolloslatuf@gmail.com

Manal Ez Eldeen, MD

CONTACT

01022454654; manal_ezeldeen@yahoo.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle investigator of Internal Medicine department

Study Record Dates

• First Submitted: March 17, 2021
• First Posted: May 12, 2021
• Study Start: August 1, 2021
• Primary Completion: March 1, 2022
• Study Completion: April 1, 2022
• Last Updated: August 19, 2021

Record last verified: 2021-08

Data Sharing

• IPD Sharing: Will not share